title: Modulation of antibody affinity by a non-contact residue.
abstract: Antibody LB4, produced by a spontaneous variant of the murine anti-digoxin monoclonal antibody 26-10, has an affinity for digoxin two orders of magnitude lower than that of the parent antibody due to replacement of serine with phenylalanine at position 52 of the heavy chain variable region (Schildbach, J.F., Panka, D.J., Parks, D.R., et al., 1991, J. Biol. Chem. 266, 4640-4647). To examine the basis for the decreased affinity, a panel of engineered antibodies with substitutions at position 52 was created, and their affinities for digoxin were measured. The antibody affinities decreased concomitantly with increasing size of the substituted side chains, although the shape of the side chains also influenced affinity. The crystal structure of the 26-10 Fab complexed with digoxin (P.D.J., R.K. Strong, L.C. Sieker, C. Chang, R.L. Campbell, G.A. Petsko, E.H., M.N.M., & S.S., submitted for publication) shows that the serine at heavy chain position 52 is not in contact with hapten, but is adjacent to a tyrosine at heavy chain position 33 that is a contact residue. The mutant antibodies were modeled by applying a conformational search procedure to position side chains, using the 26-10 Fab crystal structure as a starting point. The results suggest that each of the substituted side chains may be accommodated within the antibody without substantial structural rearrangement, and that none of these substituted side chains are able to contact hapten. These modeling results are consistent with the substituents at position 52 having only an indirect influence upon antibody affinity.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Program on Immunology, Harvard University Graduate School of Arts and Sciences, Cambridge, Massachusetts 02138.
authors.forename: J F
authors.initials: JF
authors.lastname: Schillbach
authors.forename: R I
authors.initials: RI
authors.lastname: Near
authors.forename: R E
authors.initials: RE
authors.lastname: Bruccoleri
authors.forename: E
authors.initials: E
authors.lastname: Haber
authors.forename: P D
authors.initials: PD
authors.lastname: Jeffrey
authors.forename: J
authors.initials: J
authors.lastname: Novotny
authors.forename: S
authors.initials: S
authors.lastname: Sheriff
authors.forename: M N
authors.initials: MN
authors.lastname: Margolies
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry / Q000235:genetics* / Q000276:immunology; D000915:Antibody Affinity / Q000235:genetics / Q000276:immunology*; D001483:Base Sequence; D001666:Binding Sites, Antibody / Q000235:genetics* / Q000276:immunology; D002460:Cell Line; D004076:Digoxigenin / Q000737:chemistry / Q000276:immunology; D004077:Digoxin / Q000737:chemistry / Q000276:immunology*; D051379:Mice; D008958:Models, Molecular; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D013329:Structure-Activity Relationship
chemical_list: D000911:Antibodies, Monoclonal; D004077:Digoxin; D004076:Digoxigenin